Burundi vs Democratic Republic of Congo: Number of HIV positive pregnant women receiving antiretrovirals
Number of HIV positive pregnant women receiving antiretrovirals over time
- Burundi
- Democratic Republic of Congo
How they compare
Burundi currently reports 2,670 against 2,098 in Democratic Republic of Congo, a difference of 572.
That makes Burundi's figure about 1.3 times Democratic Republic of Congo's.
The two have swapped places 1 time across 6 shared years of data; in 2004 it was Democratic Republic of Congo ahead.
Burundi ranks 22nd and Democratic Republic of Congo ranks 24th of 38 countries.
Across the 2 decades both report, Burundi averaged higher in 1 and Democratic Republic of Congo in 1.
Head to head by decade
| Decade | Burundi | Democratic Republic of Congo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 989.8 | 2,332 | 1,342 | Democratic Republic of Congo |
| 2010s | 2,670 | 2,098 | 572 | Burundi |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of hiv positive pregnant women receiving antiretrovirals, Burundi or Democratic Republic of Congo?
- Burundi, at 2,670 against 2,098 in Democratic Republic of Congo as of 2011.
- What is the difference in number of hiv positive pregnant women receiving antiretrovirals between Burundi and Democratic Republic of Congo?
- 572, with Burundi ahead.
- How many years of comparable data are there for Burundi and Democratic Republic of Congo?
- 6 years are reported by both, from 2004 to 2011.
- How do Burundi and Democratic Republic of Congo rank globally for number of hiv positive pregnant women receiving antiretrovirals?
- Burundi ranks 22nd and Democratic Republic of Congo ranks 24th of 38 countries.
- Where does this data come from?
- http://data.unaids.org/pub/GlobalReport/2008/, published as Number of HIV positive pregnant women receiving antiretrovirals. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of HIV-infected pregnant women who received antiretrovirals during the last 12 months to reduce mother-to-child transmission. The purpose of this indicator is to assess progress in preventing vertical transmission of HIV.